Karus Therapeutics
Clinical-stage biopharmaceutical company, based in Oxfordshire, UK.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD41—62m (Dealroom.co estimates Sep 2012.)
Company register number 05490954
London England (HQ)
Financials
Estimates*
| EUR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| EBITDA | (7.9m) | (6.4m) | (5.7m) | (6.6m) | (7.4m) | (4.6m) | (2.8m) |
| Profit | (5.3m) | (5.6m) | (5.2m) | (6.6m) | (7.9m) | (4.6m) | (2.8m) |
| R&D budget | - | 4.8m | 4.5m | 5.5m | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Spinout | ||
| N/A | £750k | Seed | |
£820k | Seed | ||
| N/A | £1.1m | Seed | |
£1.0m | Early VC | ||
£700k | Seed | ||
$7.6m | Series B | ||
| N/A | N/A | Series B | |
| Total Funding | CAD18.2m | ||
Related Content
Recent News about Karus Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.